Clincosm LogoSign in Get a demo

Diffuse Large B Cell Lymphoma

Showing 51 - 75 of 206
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Diffuse Large B Cell Lymphoma Trial (Bridging Radiotherapy)

Recruiting
  • Diffuse Large B Cell Lymphoma
  • Bridging Radiotherapy
  • Leeds, United Kingdom
  • +2 more
Dec 6, 2022

Non Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, DLBCL Trial in United States (KT-413)

Recruiting
  • Non Hodgkin Lymphoma
  • +3 more
  • Washington, District of Columbia
  • +5 more
Nov 29, 2022

Diffuse Large B Cell Lymphoma, High-grade B-cell Lymphoma, Primary Mediastinal Large B Cell Lymphoma Trial in Japan (epcoritamab

Recruiting
  • Diffuse Large B Cell Lymphoma
  • +5 more
  • epcoritamab (monotherapy)
  • +5 more
  • Chuo Ku, Japan
  • +19 more
Nov 22, 2022

Non-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, Follicular Lymphoma Trial in United States (JCAR017 (lisocabtagene

Active, not recruiting
  • Non-Hodgkin Lymphoma
  • +4 more
  • JCAR017 (lisocabtagene maraleucel) single-dose schedule
  • JCAR017 (lisocabtagene maraleucel) 2-dose schedule
  • Birmingham, Alabama
  • +24 more
Nov 21, 2022

Diffuse Large B Cell Lymphoma, Relapsed DLBCL, Refractory DLBCL Trial in Boston (Copanlisib, Venetoclax)

Active, not recruiting
  • Diffuse Large B Cell Lymphoma
  • +2 more
  • Duarte, California
  • +2 more
Nov 10, 2022

B-cell Lymphoma, Non Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma Trial (BN301)

Not yet recruiting
  • B-cell Lymphoma
  • +4 more
  • (no location specified)
Nov 9, 2022

Diffuse Large B Cell Lymphoma Trial (Pembrolizumab, Rituximab, Ifosfamide)

Recruiting
  • Diffuse Large B Cell Lymphoma
  • Headington, Oxford, United Kingdom
  • +1 more
Nov 2, 2022

Multiple Myeloma, Non-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma Trial in Minneapolis (Nicotinamide Expanded Haploidentical

Completed
  • Multiple Myeloma
  • +7 more
  • Nicotinamide Expanded Haploidentical or Mismatched Related Donor Natural Killer Cells
  • Minneapolis, Minnesota
    Masonic Cancer Center, University of Minnesota
Nov 2, 2022

Diffuse Large B Cell Lymphoma Trial in Colchester, Canterbury, Nottingham (R-CHOP, R-CHOP + acalabrutinib)

Recruiting
  • Diffuse Large B Cell Lymphoma
  • Colchester, Essex, United Kingdom
  • +32 more
Oct 25, 2022

Lentiviral-based Gene-edited Immune Cell Therapy

Not yet recruiting
  • Diffuse Large B Cell Lymphoma
  • +4 more
  • Pell's lentiviral-based gene-edited immune cell therapy
  • Kaohsiung, Taiwan
  • +2 more
Oct 25, 2022

Diffuse Large B Cell Lymphoma, Primary Mediastinal Large B Cell Lymphoma, Large B-cell Lymphoma Trial in Kaohsiung, Taipei

Recruiting
  • Diffuse Large B Cell Lymphoma
  • +4 more
  • CD19-targeted chimeric antigen receptor T-cell
  • Kaohsiung, Taiwan
  • +2 more
Oct 25, 2022

Diffuse Large B Cell Lymphoma, Relapsed DLBCL, Refractory DLBCL Trial in United Kingdom, United States (AUTO3)

Active, not recruiting
  • Diffuse Large B Cell Lymphoma
  • +3 more
  • AUTO3
  • Duarte, California
  • +10 more
Oct 19, 2022

Lymphoma, Follicular, Lymphoma, Mantle-Cell, Marginal Zone Lymphoma Trial in United States (ADI-001, Fludarabine,

Recruiting
  • Lymphoma, Follicular
  • +5 more
  • ADI-001
  • +2 more
  • Stanford, California
  • +6 more
Oct 19, 2022

B-cell Non Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, High-grade B-cell Lymphoma Trial in Korea, Republic of, United

Recruiting
  • B-cell Non Hodgkin Lymphoma
  • +3 more
  • Tampa, Florida
  • +8 more
Oct 17, 2022

Lymphoma, Mantle Cell Lymphoma, Follicular Lymphoma Trial in United States (Buparlisib, Ibrutinib)

Completed
  • Lymphoma
  • +3 more
  • Basking Ridge, New Jersey
  • +5 more
Oct 7, 2022

Diffuse Large B Cell Lymphoma, Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia Trial in Miami (Acalabrutinib,

Terminated
Has Results
  • Diffuse Large B Cell Lymphoma
  • +3 more
  • Miami, Florida
    University of Miami
Aug 23, 2022

Diffuse Large B Cell Lymphoma, CAR-T, Radiotherapy Trial (ultra-fraction radiotherapy)

Not yet recruiting
  • Diffuse Large B Cell Lymphoma
  • +3 more
  • ultra-fraction radiotherapy
  • (no location specified)
Aug 22, 2022

Lenalidomide Monotherapy in R/R DLBCL

Completed
  • Diffuse Large B Cell Lymphoma
    • Rochester, Minnesota
    • +56 more
    Aug 23, 2022

    Non-Hodgkin's B-cell Lymphoma, Leukemia, Lymphocytic, Chronic, B-Cell, Small Lymphocytic Leukemia Trial in Worldwide (MT-3724

    Terminated
    Has Results
    • Non-Hodgkin's B-cell Lymphoma
    • +5 more
    • MT-3724 Phase 1
    • MT-3724 Phase 2
    • Tucson, Arizona
    • +40 more
    Jul 18, 2022

    NHL, DLBCL, Non-hodgkin's Lymphoma Trial in United Kingdom, United States (AZD9150, Acalabrutinib, AZD6738)

    Completed
    • NHL
    • +3 more
    • Los Angeles, California
    • +11 more
    Aug 11, 2022

    B-Cell Lymphoma, B Acute Lymphoblastic Leukemia, Diffuse Large B Cell Lymphoma Trial in Pittsburgh (Chimeric Antigen Receptor

    Recruiting
    • B-Cell Lymphoma
    • +8 more
    • Chimeric Antigen Receptor (CAR) T-Cell Product (Autologous)
    • Pittsburgh, Pennsylvania
      AHN Cancer Institute - West Penn Hospital
    Aug 10, 2022

    Diffuse Large B Cell Lymphoma Trial in Berlin (Ibrutinib and Bortezomib + R-CHOP)

    Active, not recruiting
    • Diffuse Large B Cell Lymphoma
    • Ibrutinib and Bortezomib + R-CHOP
    • Berlin, Germany
      Charité - Universitätsmedizin Berlin, Hematology, Oncology and T
    Aug 10, 2022

    Solid Tumor, Adult, Head Neck Cancer, Non Small Cell Lung Cancer Trial in Worldwide (CX-2029)

    Active, not recruiting
    • Solid Tumor, Adult
    • +4 more
    • Birmingham, Alabama
    • +24 more
    Aug 5, 2022

    Diffuse Large B Cell Lymphoma, Chronic Lymphocytic Leukemia, Non Hodgkin Lymphoma Trial in Worldwide (KRT-232, acalabrutinib)

    Recruiting
    • Diffuse Large B Cell Lymphoma
    • +2 more
    • Goshen, Indiana
    • +44 more
    Aug 3, 2022

    Small Cell Lung Cancer, Uveal Melanoma, Ovarian Clear Cell Carcinoma Trial in United States (PLX2853)

    Completed
    • Small Cell Lung Cancer
    • +7 more
    • Scottsdale, Arizona
    • +4 more
    Jul 20, 2022